Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Total Current Liabilities data on file, last reported at $20.1 million in Q4 2025.

• Quarterly Total Current Liabilities fell 17.92% year-over-year to $20.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.1 million (down 17.92% YoY) and the FY2025 annual result came in at $20.1 million, down 17.92% from the prior year.
• Total Current Liabilities retreated to $20.1 million in Q4 2025 per LUNG's latest filing, from $22.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $24.9 million in Q1 2025 and bottomed at $14.0 million in Q1 2021.
• The 5-year median for Total Current Liabilities is $20.3 million (2022), against an average of $20.0 million.
• The widest annual swing landed in 2021, when Total Current Liabilities jumped 46.41%; it then dropped 17.92% in 2025.
• Tracing LUNG's Total Current Liabilities over 5 years: stood at $17.6 million in 2021, then advanced by 5.37% to $18.5 million in 2022, then advanced by 25.23% to $23.2 million in 2023, then increased by 5.53% to $24.4 million in 2024, then retreated by 17.92% to $20.1 million in 2025.
• Per Business Quant, the three latest LUNG Total Current Liabilities figures stand at $20.1 million (Q4 2025), $22.9 million (Q3 2025), and $22.4 million (Q2 2025).

Peer Comparison